{"transactions":[{"id":749444,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T01:55:51.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":2133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units."}],"balance_after":56242,"source":{"system":"sec-edgar","filing":"0001628280-26-041021","document":"wk-form4_1780624549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000162828026041021/wk-form4_1780624549.xml","form_type":"4"}},{"id":1129128,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T22:24:26.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":78724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on May 28, 2026, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":1352757,"source":{"system":"sec-edgar","filing":"0001628280-25-028714","document":"wk-form4_1748643848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000162828025028714/wk-form4_1748643848.xml","form_type":"4"}},{"id":1496556,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-01T00:55:09.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":32119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on May 29, 2025, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":1274033,"source":{"system":"sec-edgar","filing":"0001628280-24-026124","document":"wk-form4_1717203301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000162828024026124/wk-form4_1717203301.xml","form_type":"4"}},{"id":1917993,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T20:47:40.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":5622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":1241914,"source":{"system":"sec-edgar","filing":"0001209191-23-024670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919123024670/doc4.xml","form_type":"4"}},{"id":2138210,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-10-12T23:33:33.000Z","date":"2022-10-07","kind":"disposition_to_issuer","acquired":false,"shares":54250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding Company restricted stock units (\"RSUs\") remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that each such RSU will settle in a number of Surviving Corporation Shares equal to the number of shares subject to the award immediately before the Effective Time multiplied by 0.01."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Represents 54,250 RSUs. RSUs are scheduled to vest on March 28, 2023, subject to Mr. Mansukani's continued service through the vesting date. Prior to the Effective Time, each RSU represented a contingent right to receive one share of Company common stock and settled in common stock."},{"field":"date","element":"transactionDate","label":"F1","text":"On October 7, 2022 (the \"Closing Date\"), Convey Health Solutions Holdings, Inc. (the \"Company\") completed the transaction pursuant to which Commodore Merger Sub 2022, Inc. (\"Merger Sub\") merged with and into the Company (the \"Merger\") with the Company surviving the Merger (the \"Surviving Corporation\"). Subject to the terms and conditions of the Agreement and Plan of Merger, dated as of June 20, 2022, by and among Commodore Parent 2022, LLC, Merger Sub and the Company (the \"Merger Agreement\"), at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and designated as Rollover Shares (as defined in the Merger Agreement) was automatically converted into 0.01 shares of common stock of the Surviving Corporation (the \"Surviving Corporation Shares\"), resulting in the reporting person beneficially owning 2,066 Surviving Corporation Shares."},{"field":"date","element":"transactionDate","label":"F2","text":"In connection with the closing of the Merger, the Company notified the New York Stock Exchange (the \"NYSE\") on October 6, 2022 of the anticipated closing of the Merger on the Closing Date and that trading of the shares of Company common stock should be suspended and listing of the Company common stock on the NYSE should be removed prior to the opening of business on the Closing Date. On October 6, 2022, the closing price of a share of Company common stock was $10.51 per share."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding Company restricted stock units (\"RSUs\") remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that each such RSU will settle in a number of Surviving Corporation Shares equal to the number of shares subject to the award immediately before the Effective Time multiplied by 0.01."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents 54,250 RSUs. RSUs are scheduled to vest on March 28, 2023, subject to Mr. Mansukani's continued service through the vesting date. Prior to the Effective Time, each RSU represented a contingent right to receive one share of Company common stock and settled in common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents 54,250 RSUs. RSUs are scheduled to vest on March 28, 2023, subject to Mr. Mansukani's continued service through the vesting date. Prior to the Effective Time, each RSU represented a contingent right to receive one share of Company common stock and settled in common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.01 per share","underlying_shares":54250},"source":{"system":"sec-edgar","filing":"0000950103-22-017706","document":"dp182278_4-mansukani.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000095010322017706/dp182278_4-mansukani.xml","form_type":"4"}},{"id":2138209,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-12T23:33:33.000Z","date":"2022-10-07","kind":"disposition_to_issuer","acquired":false,"shares":438165,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On October 7, 2022 (the \"Closing Date\"), Convey Health Solutions Holdings, Inc. (the \"Company\") completed the transaction pursuant to which Commodore Merger Sub 2022, Inc. (\"Merger Sub\") merged with and into the Company (the \"Merger\") with the Company surviving the Merger (the \"Surviving Corporation\"). Subject to the terms and conditions of the Agreement and Plan of Merger, dated as of June 20, 2022, by and among Commodore Parent 2022, LLC, Merger Sub and the Company (the \"Merger Agreement\"), at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and designated as Rollover Shares (as defined in the Merger Agreement) was automatically converted into 0.01 shares of common stock of the Surviving Corporation (the \"Surviving Corporation Shares\"), resulting in the reporting person beneficially owning 2,066 Surviving Corporation Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the closing of the Merger, the Company notified the New York Stock Exchange (the \"NYSE\") on October 6, 2022 of the anticipated closing of the Merger on the Closing Date and that trading of the shares of Company common stock should be suspended and listing of the Company common stock on the NYSE should be removed prior to the opening of business on the Closing Date. On October 6, 2022, the closing price of a share of Company common stock was $10.51 per share."},{"field":"security","element":"securityTitle","label":"F3","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"security","element":"securityTitle","label":"F4","text":"The options, together representing a right to purchase 674,100 shares, consist of (i) 337,050 time-vesting options and (ii) 337,050 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Exercise price reflects a reduction of $1.18 per award from original exercise price of $7.94 as part of a special dividend as previously disclosed in the Company's proxy statement for its 2022 annual meeting of stockholders."},{"field":"date","element":"transactionDate","label":"F1","text":"On October 7, 2022 (the \"Closing Date\"), Convey Health Solutions Holdings, Inc. (the \"Company\") completed the transaction pursuant to which Commodore Merger Sub 2022, Inc. (\"Merger Sub\") merged with and into the Company (the \"Merger\") with the Company surviving the Merger (the \"Surviving Corporation\"). Subject to the terms and conditions of the Agreement and Plan of Merger, dated as of June 20, 2022, by and among Commodore Parent 2022, LLC, Merger Sub and the Company (the \"Merger Agreement\"), at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and designated as Rollover Shares (as defined in the Merger Agreement) was automatically converted into 0.01 shares of common stock of the Surviving Corporation (the \"Surviving Corporation Shares\"), resulting in the reporting person beneficially owning 2,066 Surviving Corporation Shares."},{"field":"date","element":"transactionDate","label":"F2","text":"In connection with the closing of the Merger, the Company notified the New York Stock Exchange (the \"NYSE\") on October 6, 2022 of the anticipated closing of the Merger on the Closing Date and that trading of the shares of Company common stock should be suspended and listing of the Company common stock on the NYSE should be removed prior to the opening of business on the Closing Date. On October 6, 2022, the closing price of a share of Company common stock was $10.51 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options, together representing a right to purchase 674,100 shares, consist of (i) 337,050 time-vesting options and (ii) 337,050 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."}],"balance_after":0,"derivative":{"exercise_price":6.76,"expiration_date":"2030-03-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":438165},"source":{"system":"sec-edgar","filing":"0000950103-22-017706","document":"dp182278_4-mansukani.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000095010322017706/dp182278_4-mansukani.xml","form_type":"4"}},{"id":2138208,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-12T23:33:33.000Z","date":"2022-10-07","kind":"disposition_to_issuer","acquired":false,"shares":235935,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On October 7, 2022 (the \"Closing Date\"), Convey Health Solutions Holdings, Inc. (the \"Company\") completed the transaction pursuant to which Commodore Merger Sub 2022, Inc. (\"Merger Sub\") merged with and into the Company (the \"Merger\") with the Company surviving the Merger (the \"Surviving Corporation\"). Subject to the terms and conditions of the Agreement and Plan of Merger, dated as of June 20, 2022, by and among Commodore Parent 2022, LLC, Merger Sub and the Company (the \"Merger Agreement\"), at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and designated as Rollover Shares (as defined in the Merger Agreement) was automatically converted into 0.01 shares of common stock of the Surviving Corporation (the \"Surviving Corporation Shares\"), resulting in the reporting person beneficially owning 2,066 Surviving Corporation Shares."},{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the closing of the Merger, the Company notified the New York Stock Exchange (the \"NYSE\") on October 6, 2022 of the anticipated closing of the Merger on the Closing Date and that trading of the shares of Company common stock should be suspended and listing of the Company common stock on the NYSE should be removed prior to the opening of business on the Closing Date. On October 6, 2022, the closing price of a share of Company common stock was $10.51 per share."},{"field":"security","element":"securityTitle","label":"F3","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"security","element":"securityTitle","label":"F4","text":"The options, together representing a right to purchase 674,100 shares, consist of (i) 337,050 time-vesting options and (ii) 337,050 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."},{"field":"date","element":"transactionDate","label":"F1","text":"On October 7, 2022 (the \"Closing Date\"), Convey Health Solutions Holdings, Inc. (the \"Company\") completed the transaction pursuant to which Commodore Merger Sub 2022, Inc. (\"Merger Sub\") merged with and into the Company (the \"Merger\") with the Company surviving the Merger (the \"Surviving Corporation\"). Subject to the terms and conditions of the Agreement and Plan of Merger, dated as of June 20, 2022, by and among Commodore Parent 2022, LLC, Merger Sub and the Company (the \"Merger Agreement\"), at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time and designated as Rollover Shares (as defined in the Merger Agreement) was automatically converted into 0.01 shares of common stock of the Surviving Corporation (the \"Surviving Corporation Shares\"), resulting in the reporting person beneficially owning 2,066 Surviving Corporation Shares."},{"field":"date","element":"transactionDate","label":"F2","text":"In connection with the closing of the Merger, the Company notified the New York Stock Exchange (the \"NYSE\") on October 6, 2022 of the anticipated closing of the Merger on the Closing Date and that trading of the shares of Company common stock should be suspended and listing of the Company common stock on the NYSE should be removed prior to the opening of business on the Closing Date. On October 6, 2022, the closing price of a share of Company common stock was $10.51 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's options to acquire Company common stock, whether vested or unvested, remained outstanding and continue to be subject to the same terms and conditions as immediately prior to the Effective Time, as set forth in the applicable plan and award agreement, except that: (i) each such option is exercisable for that number of Surviving Corporation Shares equal to the product of (A) the number of shares of Company common stock subject to the option immediately before the Effective Time multiplied by (B) 0.01; and (ii) the per share exercise price for each Surviving Corporation Share issuable upon exercise of such option is equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of such option immediately before the Effective Time by (B) 0.01."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options, together representing a right to purchase 674,100 shares, consist of (i) 337,050 time-vesting options and (ii) 337,050 performance-vesting options. Time-vesting options are subject to a five-year time-based vesting schedule, with 20% vesting on September 4, 2020 and the remainder vesting in 16 equal installments every three months thereafter. Performance-vesting options vest over a five-year performance period commencing in 2019, with 20% of the stock options eligible to vest each year of the performance period based on achievement of certain financial metrics."}],"balance_after":0,"derivative":{"exercise_price":7.94,"expiration_date":"2030-03-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":235935},"source":{"system":"sec-edgar","filing":"0000950103-22-017706","document":"dp182278_4-mansukani.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000095010322017706/dp182278_4-mansukani.xml","form_type":"4"}},{"id":2293704,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-20T20:56:13.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":6936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":1236292,"source":{"system":"sec-edgar","filing":"0001209191-22-025015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919122025015/doc4.xml","form_type":"4"}},{"id":2314116,"issuer":{"id":123140,"kind":"organization","name":"Convey Health Solutions Holdings, Inc.","symbol":"CNVY"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-03-30T20:42:50.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":54250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units are scheduled to vest on the earlier of March 28, 2023 and the day immediately prior to the date of the next annual meeting of the shareholders of Convey Health Solutions Holdings, Inc. (the \"Issuer\") following March 28, 2022, subject to Mr. Mansukani's continued service with the Issuer through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units are scheduled to vest on the earlier of March 28, 2023 and the day immediately prior to the date of the next annual meeting of the shareholders of Convey Health Solutions Holdings, Inc. (the \"Issuer\") following March 28, 2022, subject to Mr. Mansukani's continued service with the Issuer through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units are scheduled to vest on the earlier of March 28, 2023 and the day immediately prior to the date of the next annual meeting of the shareholders of Convey Health Solutions Holdings, Inc. (the \"Issuer\") following March 28, 2022, subject to Mr. Mansukani's continued service with the Issuer through the applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in common stock."}],"balance_after":54250,"derivative":{"underlying":"Common Stock, par value $0.01 per share","underlying_shares":54250},"source":{"system":"sec-edgar","filing":"0001104659-22-040171","document":"tm2210674-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000110465922040171/tm2210674-6_4seq1.xml","form_type":"4"}},{"id":2569158,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Rights to Buy)","published_at":"2021-09-15T21:20:23.000Z","date":"2021-09-14","kind":"exercise","acquired":false,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on April 27, 2017, and fully vested on July 1, 2020."}],"balance_after":493750,"derivative":{"exercise_price":1,"expiration_date":"2027-04-27","underlying":"Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001209191-21-056204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919121056204/doc4.xml","form_type":"4"}},{"id":2569157,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T21:20:23.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":156250,"price":28.98,"value":4528125.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units."}],"balance_after":1229356,"source":{"system":"sec-edgar","filing":"0001209191-21-056204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919121056204/doc4.xml","form_type":"4"}},{"id":2569156,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T21:20:23.000Z","date":"2021-09-14","kind":"exercise","acquired":true,"shares":156250,"price":1,"value":156250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units."}],"balance_after":1385606,"source":{"system":"sec-edgar","filing":"0001209191-21-056204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919121056204/doc4.xml","form_type":"4"}},{"id":2746820,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-16T21:28:24.000Z","date":"2021-04-14","kind":"grant","acquired":true,"shares":6956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vests in full on April 14, 2022, subject to continued service as a director."}],"balance_after":1229356,"source":{"system":"sec-edgar","filing":"0001209191-21-027019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919121027019/doc4.xml","form_type":"4"}},{"id":3489415,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-14T23:32:57.000Z","date":"2019-06-12","kind":"tax_withholding","acquired":false,"shares":25829,"price":4.46,"value":115197.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Mansukani's tax withholding obligations on shares acquired on June 12, 2019."}],"balance_after":71523,"source":{"system":"sec-edgar","filing":"0001209191-19-037302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919119037302/doc4.xml","form_type":"4"}},{"id":3489414,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-14T23:32:57.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":53812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Mansukani on June 12, 2019 in consideration of his services on Endo International plc's Board of Directors."}],"balance_after":97352,"source":{"system":"sec-edgar","filing":"0001209191-19-037302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919119037302/doc4.xml","form_type":"4"}},{"id":3879208,"issuer":{"id":165258,"kind":"organization","name":"KINDRED HEALTHCARE, INC","symbol":"KND"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-02T13:10:01.000Z","date":"2018-07-02","kind":"disposition_to_issuer","acquired":false,"shares":38512,"price":9,"value":346608.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-040221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060009/000120919118040221/doc4.xml","form_type":"4"}},{"id":3896626,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-12T20:16:56.000Z","date":"2018-06-08","kind":"tax_withholding","acquired":false,"shares":15019,"price":7.67,"value":115195.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Mansukani's tax withholding obligations on shares acquired on June 8, 2018."}],"balance_after":43540,"source":{"system":"sec-edgar","filing":"0001209191-18-037221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919118037221/doc4.xml","form_type":"4"}},{"id":3896625,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-12T20:16:56.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":31291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Mansukani on June 8, 2018 in consideration of his services on Endo International plc's Board of Directors."}],"balance_after":58559,"source":{"system":"sec-edgar","filing":"0001209191-18-037221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919118037221/doc4.xml","form_type":"4"}},{"id":4165362,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-11-13T21:07:40.000Z","date":"2017-11-08","kind":"tax_withholding","acquired":false,"shares":3206,"price":6.09,"value":19524.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Mansukani's tax withholding obligations on shares acquired."}],"balance_after":27268,"source":{"system":"sec-edgar","filing":"0001209191-17-060276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919117060276/doc4.xml","form_type":"4"}},{"id":4165361,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-11-13T21:07:40.000Z","date":"2017-11-08","kind":"grant","acquired":true,"shares":6681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Mansukani on November 8, 2017 in consideration of his anticipated services on Endo International plc's Board of Directors."}],"balance_after":30474,"source":{"system":"sec-edgar","filing":"0001209191-17-060276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000120919117060276/doc4.xml","form_type":"4"}},{"id":4305190,"issuer":{"id":165258,"kind":"organization","name":"KINDRED HEALTHCARE, INC","symbol":"KND"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-25T12:12:50.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":14852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock granted to the reporting person. These shares will fully vest on 5/24/2018."}],"balance_after":38512,"source":{"system":"sec-edgar","filing":"0001209191-17-035210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060009/000120919117035210/doc4.xml","form_type":"4"}},{"id":4372408,"issuer":{"id":177510,"kind":"organization","name":"Surgical Care Affiliates, Inc.","symbol":"SCAI"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2017-03-24T21:16:36.000Z","date":"2017-03-24","kind":"disposition_to_issuer","acquired":false,"shares":9921,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the \"Merger Agreement,\" and the merger contemplated thereby, the \"Merger\") by and among Surgical Care Affiliates, Inc. (\"SCA\"), UnitedHealth Group Incorporated (\"UHG\"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) $57 divided by $169.42 (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer), rounded down to the nearest whole share (such quotient, the \"Equity Award Conversion Ratio\"), at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options became vested as to all of the shares of Common Stock underlying such options on June 29, 2012 and became exercisable on September 16, 2013."}],"balance_after":0,"derivative":{"exercise_price":12.1,"expiration_date":"2021-08-01","underlying":"Common Stock","underlying_shares":9921},"source":{"system":"sec-edgar","filing":"0000903423-17-000219","document":"mansukani.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411574/000090342317000219/mansukani.xml","form_type":"4"}},{"id":4372407,"issuer":{"id":177510,"kind":"organization","name":"Surgical Care Affiliates, Inc.","symbol":"SCAI"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-24T21:16:36.000Z","date":"2017-03-24","kind":"disposition_to_issuer","acquired":false,"shares":11569,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the \"Merger Agreement,\" and the merger contemplated thereby, the \"Merger\") by and among Surgical Care Affiliates, Inc. (\"SCA\"), UnitedHealth Group Incorporated (\"UHG\"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects 11,569 shares of Common Stock underlying restricted stock units (\"RSUs\") of the issuer, all of which were subject to time-based vesting. Each RSU represents a contingent right to acquire one share of Common Stock. Immediately prior to the effective time of the Merger (the \"Effective Time\"), all of these RSUs were vested (8,441 of which had previously vested and 3,128 of which vested in connection with the Merger) and settled in shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each share of Common Stock was cancelled and converted into the right to receive $11.40 in cash and a number of shares of UHG common stock equal to $45.60 divided by $169.42 (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the \"Exchange Offer\")), with the fractional shares being paid in cash, as provided in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000903423-17-000219","document":"mansukani.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411574/000090342317000219/mansukani.xml","form_type":"4"}},{"id":4400203,"issuer":{"id":177510,"kind":"organization","name":"Surgical Care Affiliates, Inc.","symbol":"SCAI"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-06T16:47:37.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":1059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units of the issuer, vesting ratably in equal annual installments over a period of two years from March 2, 2017, pursuant to the Surgical Care Affiliates, Inc. 2016 Omnibus Long-Term Incentive Plan (the \"Plan\"), which is exempt under Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,569 shares of Common Stock underlying restricted stock units (\"RSUs\") of the issuer, all of which are subject to time-based vesting. As of the date hereof, 8,441 of the RSUs were vested, with the remaining RSUs vesting on the following schedule: 978 RSUs vesting on June 4, 2017, 1,621 RSUs vesting on March 2, 2018 and 529 RSUs vesting on March 2, 2019. Each vested RSU is settled on the earlier of the individual's termination of employment (as defined in the Plan) or a change in control of the issuer."}],"balance_after":11569,"source":{"system":"sec-edgar","filing":"0001590503-17-000046","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411574/000159050317000046/edgar.xml","form_type":"4"}},{"id":4590020,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Optoin (right to buy)","published_at":"2016-10-03T22:50:19.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share."}],"balance_after":0,"derivative":{"exercise_price":3.2,"exercise_date":"2015-04-21","expiration_date":"2020-07-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001595262-16-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000159526216000057/edgar.xml","form_type":"4"}},{"id":4590019,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Optoin (right to buy)","published_at":"2016-10-03T22:50:19.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,840 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share."}],"balance_after":0,"derivative":{"exercise_price":5.8,"exercise_date":"2013-04-21","expiration_date":"2020-07-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001595262-16-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000159526216000057/edgar.xml","form_type":"4"}},{"id":4590018,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Optoin (right to buy)","published_at":"2016-10-03T22:50:19.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2012-04-21","expiration_date":"2020-07-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001595262-16-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000159526216000057/edgar.xml","form_type":"4"}},{"id":4590017,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":41315,"kind":"person","name":"Mansukani Sharad","position":1,"cik":"0001402190","reported_name":"Mansukani Sharad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-03T22:50:19.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":42840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. (\"Quintiles\") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the \"merger\"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to merger agreement in exchange for 16,450 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001595262-16-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402190/000159526216000057/edgar.xml","form_type":"4"}}]}